Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950660 · ClinicalTrials.gov registry record · Phase 4
Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion
A Phase 4 study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT04950660 is a Phase 4 study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 61 participants.
The verdict
NCT04950660, a Phase 4 study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
Prospective, randomized control trial To determine if oral caffeine decreases the frequency of opioid demand in children with adolescent idiopathic scoliosis after their spinal fusion surgery To compare pain scale ratings, number of requests for diazepam, average heart rate, average blood pressure, sex, age, ethnicity, post-op day of discharge, operative time, estimated intraoperative blood loss, remittance post-surgery, length of hospital stay, and segments fused during spinal fusion surgery.
Interventions
- DRUG Placebo
- DRUG Caffeine Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-12-11 |
| Est. Completion | 2024-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04950660
The ClinicalTrials.gov registry entry for NCT04950660 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04950660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04950660 about?
NCT04950660 is a clinical study titled "Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion". Prospective, randomized control trial To determine if oral caffeine decreases the frequency of opioid demand in children with adolescent idiopathic scoliosis after their spinal fusion surgery To compare pain scale ratings, number of requests for diazepam, average heart rate, average blood pressure, ...
What is the current status of trial NCT04950660?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2019-12-11. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT04950660?
The interventions under investigation include: Placebo (DRUG), Caffeine Tablet (DRUG).
Who is sponsoring clinical trial NCT04950660?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.